GT Biopharma Inc (GTBP)
3.17
+0.17
(+5.67%)
USD |
NASDAQ |
May 01, 16:00
3.17
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma Total Return Price: 3.17 for May 1, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 30, 2024 | 3.00 |
| April 29, 2024 | 3.107 |
| April 26, 2024 | 3.345 |
| April 25, 2024 | 3.752 |
| April 24, 2024 | 3.65 |
| April 23, 2024 | 3.65 |
| April 22, 2024 | 3.78 |
| April 19, 2024 | 3.69 |
| April 18, 2024 | 3.800 |
| April 17, 2024 | 3.97 |
| April 16, 2024 | 3.70 |
| April 15, 2024 | 3.80 |
| April 12, 2024 | 3.90 |
| April 11, 2024 | 4.00 |
| April 10, 2024 | 4.00 |
| April 09, 2024 | 4.15 |
| April 08, 2024 | 4.08 |
| April 05, 2024 | 4.150 |
| April 04, 2024 | 4.362 |
| April 03, 2024 | 4.65 |
| April 02, 2024 | 4.20 |
| April 01, 2024 | 4.31 |
| March 28, 2024 | 4.43 |
| March 27, 2024 | 4.37 |
| March 26, 2024 | 4.40 |
| Date | Value |
|---|---|
| March 25, 2024 | 4.41 |
| March 22, 2024 | 4.59 |
| March 21, 2024 | 3.81 |
| March 20, 2024 | 4.21 |
| March 19, 2024 | 4.465 |
| March 18, 2024 | 4.41 |
| March 15, 2024 | 4.63 |
| March 14, 2024 | 4.71 |
| March 13, 2024 | 4.57 |
| March 12, 2024 | 5.130 |
| March 11, 2024 | 4.848 |
| March 08, 2024 | 4.32 |
| March 07, 2024 | 4.407 |
| March 06, 2024 | 4.332 |
| March 05, 2024 | 4.30 |
| March 04, 2024 | 4.530 |
| March 01, 2024 | 4.40 |
| February 29, 2024 | 4.22 |
| February 28, 2024 | 4.19 |
| February 27, 2024 | 4.13 |
| February 26, 2024 | 3.95 |
| February 23, 2024 | 3.87 |
| February 22, 2024 | 4.197 |
| February 21, 2024 | 4.04 |
| February 20, 2024 | 4.43 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
3.00
Minimum
Apr 30 2024
568.80
Maximum
Jun 02 2021
102.49
Average
81.60
Median
Sep 12 2019
Total Return Price Benchmarks
| Cutera Inc | 2.455 |
| Outlook Therapeutics Inc | 8.51 |
| 180 Life Sciences Corp | 2.04 |
| Journey Medical Corp | 3.58 |
| NovaBay Pharmaceuticals Inc | 0.0892 |